August 16, 2019
American Health Line rounds up the latest health care news in the states.
August 15, 2019
FDA on Wednesday approved a new antibiotic, called pretomanid, to treat highly drug-resistant strains of tuberculosis, which kills about 500,000 of the 1.6 million individuals who die annually from the infectious disease.
A survey by the National Business Group on Health of 147 large employers that cover more than 15.6 million people revealed that employers are sharply divided on so-called “Medicare-for-All” proposals—and are planning to implement their own ideas to lower health care costs.
Drugmakers and health systems are entering into agreements to share patients' genetic information for research purposes—but these sometimes-exclusive deals are attracting pushback from some ethics and privacy experts.
August 14, 2019
Health officials on Monday announced that two experimental treatments appear to have improved the survival rates of patients infected with the Ebola virus, and the treatments now will be offered to all patients in the Democratic Republic of Congo who have contracted the virus.
A patient's geographic region is strongly correlated with whether he or she receives a high-intensity statin after a heart attack, according to a study recently published in JAMA Cardiology.
August 13, 2019
U.S. hospitals and infusion clinics are rationing a medicine approved to treat immune disorders and suspending treatment for many patients who use the drug amid a nationwide shortage.
August 12, 2019
Experts say the common brand-name products used for IV iron infusions in many cases are medically interchangeable—yet providers increasingly are administering the most costly products, leaving patients facing unexpectedly high bills.
Drugmakers increasingly are creating generic versions of their own brand-name drugs, aiming in part to sustain revenue after patents expire, but some critics say these so-called "authorized generics" stifle competition and ultimately could increase prices.
August 9, 2019
Advisory Board. All rights reserved.